Jump to any asset 724 assets, updated daily
UnitedHealth Group Incorporated vs The Cigna Group
VS
Last updated: (9h 49m ago) • UNH at $408.74, CI at $278.40
CleaRank Financial AI • Data from TwelveData
Reviewed by CleaRank editorial team. Data refreshed daily. Not financial advice.
Comparative Analysis
Centene Corporation (CI) emerges as the preferred investment over UnitedHealth Group (UNH) primarily due to its significantly more attractive valuation. While both are major players in the health insurance sector, CI offers a compelling combination of lower valuation multiples and stronger revenue growth, suggesting greater upside potential. UNH, despite its larger scale and robust profitability, trades at a premium that may limit near-term appreciation. Investors seeking value and growth should favor CI at this juncture.
Key Differentiator
The most significant differentiator between UNH and CI is valuation. CI's P/E ratio of 11.69 is less than half of UNH's 30.68, indicating that investors are paying a much lower price for each dollar of earnings. This substantial valuation gap, combined with CI's superior revenue growth, makes it the more attractive option for investors prioritizing value and top-line expansion.
Joint Outlook
Looking ahead 6-12 months, Centene Corporation (CI) is positioned for potential outperformance driven by its value appeal and continued revenue expansion. If CI can maintain its growth momentum and leverage its lower valuation, it could see significant price appreciation. UnitedHealth Group (UNH), while a stable and profitable company, faces headwinds from its high valuation and slower growth. Its outlook is more dependent on consistent execution and potentially a broader market rally that lifts all stocks, rather than specific catalysts for outperformance.
Price Analysis Comparison
Valuation Metrics
| Metric | UNH | CI |
|---|---|---|
| P/E Ratio | 30.68 | 11.69 |
| Market Cap | 371.19B | 73.56B |
| Price/Sales | 0.82 | 0.26 |
| Price/Book | 3.53 | 1.75 |
| EV/EBITDA | 16.99 | 7.80 |
| Dividend Yield | N/A | N/A |
Centene Corporation (CI) presents a more compelling valuation profile compared to UnitedHealth Group (UNH). CI trades at a Price-to-Earnings (P/E) ratio of 11.69, which is substantially lower than UNH's P/E of 30.68. This suggests that CI's earnings are priced more favorably in the market. Furthermore, CI's market capitalization of $73.56 billion is considerably smaller than UNH's $371.19 billion, indicating that CI may have more room for growth as it scales. The lower P/E for CI, coupled with its solid revenue growth, points to a potentially undervalued asset.
Profitability & Efficiency
| Metric | UNH | CI |
|---|---|---|
| Rev. Growth (Qtly) | 0.40% | 6.70% |
| Profit Margin | 3.14% | 2.27% |
| Return on Equity | 14.15% | 16.76% |
| Return on Assets | 4.38% | 4.46% |
| Debt/Equity | 69.21 | 74.29 |
UnitedHealth Group (UNH) exhibits a slightly stronger return on equity (ROE) at 14.15% compared to Centene Corporation's (CI) 16.76%. However, UNH boasts a higher net profit margin of 3.14% versus CI's 2.27%. UNH also shows a marginally better return on assets (ROA) at 4.38% compared to CI's 4.46%. While CI's ROE is higher, UNH's superior net profit margin and ROA suggest better overall operational efficiency and profitability on a per-dollar-of-revenue and per-dollar-of-asset basis, though CI's ROE is very competitive.
Earnings Reality Check
UNH
Last 5 Qs: UNH beat estimates 3x out of 5. Rose 3x after beats.
CI
Last 5 Qs: CI beat estimates 4x out of 5. Fell 2x after beats. (Sell the news?)
Technical Indicators
| Indicator | UNH | CI |
|---|---|---|
| RSI (14) | 31.24 | 41.89 |
| 50-Day MA | $413.32 | $285.69 |
| 200-Day MA | $346.15 | $279.24 |
Both UNH and CI are exhibiting bearish technical signals as of August 2026. UNH's RSI is 31.24 and its MACD is -1.97, indicating significant downward momentum and oversold conditions. Its price is below its 50-day ($413.32) and 200-day ($346.15) moving averages. CI's RSI is 41.89 and its MACD is -2.68, also suggesting bearish momentum but less extreme than UNH. CI's price is trading below its 50-day ($285.69) moving average but is slightly above its 200-day ($279.24) average. CI's technicals are slightly less bearish than UNH's, particularly its position relative to the 200-day SMA.
AI Analyst Sentiment
UNH
Hold
Technical Score: 55/100
CI
Hold
Technical Score: 55/100
While specific analyst ratings and institutional positioning data are not provided, the current market prices and technical indicators suggest a cautious sentiment for both UnitedHealth Group (UNH) and Centene Corporation (CI). UNH's premium valuation and slower revenue growth may temper bullish sentiment among some investors. Conversely, CI's lower valuation and higher revenue growth could attract value-oriented investors, but its slightly weaker technicals might indicate some lingering concerns or a less robust immediate outlook.
Risk Stratification
| Metric | UNH | CI |
|---|---|---|
| Beta (Volatility) | 0.63 | 0.32 |
| Sharpe Ratio | -0.08 | -0.25 |
For UnitedHealth Group (UNH), key risks include potential regulatory changes impacting the healthcare industry, increased competition, and the sheer scale of its operations which can lead to slower innovation or integration challenges. Its high valuation also presents a risk if growth expectations are not met. Centene Corporation (CI) faces risks related to its heavy reliance on government programs, potential shifts in Medicaid policy, and execution risks associated with its growth strategies. Its lower profit margins compared to UNH also make it more susceptible to cost pressures.
Comparative ProTips
- Prioritize CI for its significant valuation discount and stronger revenue growth trajectory.
- Monitor regulatory developments in the healthcare sector, as they can impact both UNH and CI.
- Consider UNH for its superior profitability margins if a long-term, stable income stream is the primary objective, though valuation is a concern.
Monte Carlo Projection (10yr)
Actionable Trade Plans
Compare entry, exit, and risk management levels for both assets
Select Your Trade Bias
Risk Tolerance
Conservative 3% Aggressive
Portfolio Value
$ ✎
Position Size: $200 - $300 per asset
UNH
Current: $408.74
ENTRY ZONES
Conservative
$388.30
Aggressive
$408.74
RISK MANAGEMENT
STOP LOSS
$376.65
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5%
$407.72
+10%
$427.13
+15%
$446.55
CI
Current: $278.40
ENTRY ZONES
Conservative
$264.48
Aggressive
$278.40
RISK MANAGEMENT
STOP LOSS
$256.55
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5%
$277.70
+10%
$290.93
+15%
$304.15
Calculate Your Trade
ℹ️ Disclaimer
This comparison involves assets with varying risk profiles. The content is for educational purposes only. Identifying the stronger asset is based on relative strength (RS) and technical convergence. Past correlation does not guarantee future lockstep movement. Trading involves risk of loss. Note: The AI favored CI based on relative valuation. This is valid for the specified timeframe only.